Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Eylea

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Eylea was produced by Bayer.

After Lucentis setback, Novartis trumpets data on follow-up drug

After Lucentis setback, Novartis trumpets data on follow-up drug of Lucentis and Eylea for AMD, even though Avastin isn’t approved for the indication. ... Meanwhile, Eylea has been gaining ground in wet AMD thanks to less frequent dosing, accord to GlobalData.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin The two pharma companies mounted the legal challenge to stop the 12 Clinical Commissioning Groups (CCGs) in the north east of England from using Avastin in place of Bayer’s Eylea ... The cost implications are clear, as the court judgement showed: it

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III

Allergan’s abicipar matches AMD blockbuster Lucentis in phase III Bayer's Eylea remains the drug to beat, however. Allergan has positive phase III results for a wet age-related macular degeneration (AMD) drug that seems to be at least as ... Both studies will continue for another year. Lucentis – sold by Roche in the

Regeneron’s Dupixent and Praluent falls short

Regeneron’s Dupixent and Praluent falls short Regeneron’s chief executive Len Schleifer said on a conference call that global sales of Eylea were $1.6bn, with Regeneron booking $984m, up 15%. ... Nevertheless, Schleifer told analysts that Dupixent and the immuno-oncology pipeline in particular are

Shaping healthcare

Shaping healthcare Or with our other big growth product Eylea, a VEGF treatment for the retina, we have 80, 000 patients under treatment as we speak.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...